Impaired Production of Interferon-?? and Tumor Necrosis Factor-?? but not of Interleukin 10 in Whole Blood of Patients with Sepsis
- 1 February 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Shock
- Vol. 19 (2) , 113-116
- https://doi.org/10.1097/00024382-200302000-00004
Abstract
It has been demonstrated that lipopolysaccharide (LPS)-induced cytokine response in patients with sepsis differ from the normal host, yet this has not been controlled for the presence of underlying disease. We studied the ability of LPS and killed gram-negative bacteria (GNB) to induce tumor necrosis factor (TNF)-α and interleukin (IL) 10, and of phytohemagglutinin (PHA) to induce interferon (IFN)-γ, in whole blood from patients with sepsis (SP, n = 20), patients with matched underlying disease and without sepsis (control patients, n = 20), and healthy volunteers (HV, n = 20). LPS-induced TNF-α production was lower in SP (median = 638 pg/mL) compared with control patients (4060 pg/mL;P = 0.003), and control patients production was lower compared with HV (5329 pg/mL;P < 0.001). Pseudomonas aeruginosa-induced TNF-α production was lower in SP (1443 pg/mL) than in control patients (7319 pg/mL;P < 0.05), and was not different between control patients and HV (6612 pg/mL;P = 0.6). IFNγ production was lower in SP (948 pg/mL) compared with control patients (5516 pg/mL;P < 0.001), and the control patients production was lower compared with HV (11,282 pg/mL;P < 0.001). IL-10 production was not different among the three groups. Down-regulation of TNF-α production in patients with sepsis, although not restricted to them, was more pronounced with LPS than with GNB. Although the presence of underlying disease may be involved in the regulatory mechanisms of host response, the use of controls with matched underlying diseases provides strong evidence for the septic condition in the down-regulation of inflammatory response in patients with sepsis.Keywords
This publication has 22 references indexed in Scilit:
- SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITYShock, 2001
- Bloodstream infections: Epidemiology, pathophysiology and therapeutic perspectivesInfection, 1999
- Tumornekrosefaktor alpha (TNF alpha) und Sepsis: Bedeutung für die WirtsabwehrInfection, 1996
- The role of IL-10 in crossregulation of TH1 and TH2 responsesImmunology Today, 1991
- Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic ShockThe Journal of Infectious Diseases, 1990
- Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis.The Journal of Experimental Medicine, 1989
- The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infectionCell, 1989
- Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.The Journal of Experimental Medicine, 1988
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985